Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Biotech stocks are in a slump. Despite numerous wins in the high-profile areas of COVID-19
Biotech stocks are in a slump. Despite numerous wins in the high-profile areas of COVID-19
Credit: Pixabay/CC0 Public Domain News that the Novavax COVID-19 vaccine has shown about 60% efficacy
What happened Shares of the COVID-19 vaccine developers Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) are both